Pterygium surgery removes a wedge-shaped growth of tissue from the surface of the eye and replaces it with healthy tissue to prevent the growth from coming back. The procedure is outpatient, typically takes 20 to 40 minutes, and most people return to work within two weeks. It’s one of the most common eye surgeries worldwide, performed when a pterygium threatens vision, causes persistent discomfort, or restricts eye movement.
Why Pterygium Surgery Is Needed
A pterygium is a fleshy, triangular growth that develops on the conjunctiva, the clear membrane covering the white of your eye. It almost always starts on the side closest to your nose and grows slowly toward the center of the eye. Many pterygia stay small and never need treatment beyond lubricating eye drops. Surgery becomes necessary when the growth starts causing real problems.
The most common reasons for surgery are decreased vision from the growth creeping over the pupil, irregular astigmatism (where the growth warps the shape of the cornea and distorts vision), chronic pain or inflammation that won’t settle with drops, restricted eye movement, and cosmetic concern. Surgeons grade pterygia by how far they’ve advanced from the limbus (the border between the white of the eye and the cornea). A Grade 1 growth extends less than 2 mm onto the cornea, Grade 2 reaches 2 to 4 mm, and Grade 3 extends beyond 4 mm. Growths that have reached or crossed the edge of the pupil are the most urgent candidates for surgery, since waiting longer risks permanent scarring in the line of sight.
How the Surgery Works
The procedure is performed under local anesthesia. You’re awake but your eye is completely numbed, so you won’t feel pain during the operation. The surgeon first carefully peels the pterygium away from the cornea and removes it along with the abnormal tissue underneath. What happens next depends on the technique used to cover the exposed area, and this step is the most important factor in whether the growth comes back.
Conjunctival Autograft
This is the gold-standard technique. After removing the pterygium, the surgeon takes a thin piece of healthy conjunctiva from under your upper eyelid (where it’s hidden and won’t be missed) and transplants it over the bare area. The graft is carefully oriented so that the limbal edge of the transplanted tissue lines up with the limbal border where the pterygium used to sit. This matters because the limbus contains stem cells that maintain a healthy corneal surface and act as a barrier against regrowth.
The autograft approach reduces recurrence rates to roughly 5% to 15%, and when combined with an anti-scarring agent applied during surgery, recurrence can drop to near zero. In one comparative study, conjunctival autograft with an adjunctive anti-scarring medication had a 0% recurrence rate across treated eyes. Without that medication, the rate was about 18%, which is still far better than alternatives.
Amniotic Membrane Transplant
Instead of using your own tissue, this technique covers the bare area with a piece of processed amniotic membrane (the innermost layer of the placenta). It’s a reasonable option when a conjunctival autograft isn’t feasible, for example if you’ve had previous eye surgeries that used up available conjunctival tissue, or if both eyes need surgery at the same time. However, recurrence rates are significantly higher. In the same comparative study, amniotic membrane grafts had recurrence rates of 46% to 80%, depending on whether an anti-scarring agent was used alongside them.
Bare Sclera Excision
This older, simpler approach removes the pterygium and leaves the exposed white of the eye to heal on its own without any graft. It’s faster, but it carries the highest recurrence rates of any technique, often exceeding 50%. For that reason, most surgeons no longer recommend it as a standalone procedure.
Fibrin Glue vs. Sutures
Once the graft is positioned, it needs to be secured. Traditionally, surgeons stitched the graft in place with tiny sutures. Now, many use fibrin glue, a biological adhesive, instead. The difference for patients is significant. Fibrin glue cuts average surgery time from about 41 minutes down to roughly 23 minutes. More importantly, patients in the glue group report less stinging, less watering, and less pain at both the three-day and ten-day marks after surgery. The glue dissolves on its own, so there’s no suture removal appointment and no scratchy stitch sensation during healing.
What Recovery Looks Like
You’ll go home the same day with a patch or shield over your eye. Here’s a realistic timeline of what to expect:
- First week: Your eye will be noticeably sore. You’ll use antibiotic and anti-inflammatory drops several times a day. Wear the protective shield at night, avoid rubbing your eye, and skip makeup.
- Weeks 2 to 3: The redness fades gradually over this period. Most people can return to work after about two weeks, though that depends on your job. Office work is fine sooner than dusty or physically demanding environments.
- Weeks 4 to 6: Your vision may stay somewhat blurry for up to six weeks as the surface heals and the graft settles. It should return to where it was before surgery. Avoid swimming for at least four weeks.
During the first two weeks, avoid bending over, jogging, cycling, aerobics, and other strenuous activity. Dusty or windy environments can irritate the healing surface, so steer clear of those as well. Don’t color or perm your hair for at least ten days.
Eye drops are typically tapered over about two months. You’ll start with antibiotic and steroid drops four times daily in the first week, then reduce by one drop per week over the next month. After that, you may switch to a milder anti-inflammatory drop twice daily for another four weeks.
Possible Complications
Pterygium surgery is safe, but like any surgery it carries risks. A large retrospective study of over 2,300 eyes documented the most common complications after conjunctival autograft surgery:
- Graft retraction: The transplanted tissue pulled back from its intended position in about 29% of cases. This is usually minor and doesn’t require a second procedure.
- Subconjunctival hemorrhage: A harmless patch of blood under the surface appeared in about 39% of eyes. It looks alarming but resolves on its own within a couple of weeks.
- Graft swelling: Occurred in about 22% of cases and typically settles as the eye heals.
- Recurrence: The pterygium grew back in 1.4% of cases in this series.
- Graft loss: The transplanted tissue failed to survive in under 1% of cases.
- Granuloma: A small inflammatory bump formed at the surgical site in less than 0.5% of cases.
Serious complications like corneal melting are extremely rare, occurring in roughly 1 in 2,500 eyes, almost exclusively in cases where a recurrent pterygium was being removed for the second or third time. Recurrent pterygia have higher complication rates across the board, including more bleeding, swelling, graft loss, and regrowth, which is one reason surgeons aim to get the best possible result on the first operation.
What Affects Your Outcome
The biggest factor in long-term success is the surgical technique. Conjunctival autograft with an anti-scarring agent consistently produces the lowest recurrence rates. Beyond technique, UV exposure plays a major role. Pterygia are strongly associated with sun and wind exposure, and that same exposure drives recurrence after surgery. Wearing wraparound sunglasses outdoors after recovery isn’t just a suggestion; it’s one of the most effective things you can do to protect the result.
People under 40 tend to have higher recurrence rates than older patients, likely because their tissue heals more aggressively. Larger or more vascular pterygia at the time of surgery also carry greater risk of regrowth. If your pterygium is still small but you’re considering surgery mainly for cosmetic reasons, it’s worth weighing the timing carefully, since a smaller growth means a simpler operation and a better chance of a clean outcome.